|
|
|
|
|
Last Trade
|
Last Trade:
$104.03
|
Change:
-3.76 (-3.49%)
|
Trade Time:
01:39 PM EST
|
Market Cap:
$1.83B
|
|
|
|
|
|
|
Description of Business
|
|
We are a biopharmaceutical company focused on developing and acquiring
technologies that help pharmaceutical companies discover and develop medicines.
Over our more than 30 year history, we have employed research technologies such
as nuclear receptor assays, high throughput computer screening, formulation
science, liver targeted pro-drug technologies and antibody discovery
technologies to assist companies in their work toward securing prescription drug
approvals. We currently have partnerships and license agreements with over 95
pharmaceutical and biotechnology companies, and over 165 different programs
under license with us are currently in various stages of commercialization and
development. We have contributed novel research and technologies for approved
medicines that treat cancer, osteoporosis, fungal infections and low blood
platelets, among others.
|
|
|
|